Baraka

Baraka is administered as an adjunct to antitussive treatment in viral respiratory infections and to hypoglycaemic treatment in patients with known changes in their glycaemic profile (type 2 diabetes mellitus, altered basal glycaemia) in combination with lifestyle changes (balanced meals, low-carbohydrate diet and exercise within the limits of tolerance). Baraka has also been found to have antihistamine, antiviral and antioxidant effects.

Baraka is administered to adults as follows:

• Baraka, 450 mg tablets: between 1 and 3 tablets per day for one month or in consecutive 10-day courses for 3 to 6 months for the antioxidant effect; Used as a cough suppressant: 1 tablet 3 times a day for a maximum of 5-7 days. Do not take more than 4 tablets of 450 mg in 24 hours.
• Baraka forte, 500 mg tablets: between 1 and 2 tablets per day; Do not take more than 2 tablets of 500 mg in 24 hours.

Baraka is administered to children over 12 years of age as follows:

1 tablet of 100 mg 3 times a day, not exceeding 20 mg/kg body weight per day. It should be administered for a maximum of one month.

The tablets should preferably be taken before main meals.

For administration of Baraka for longer than one month, it is recommended to seek medical advice.

Baraka tablets contain oil produced from the seeds of Nigella sativa, also known as ‘black cumin’ or ‘nigella sativa’. These black cumin seeds contain saturated and polyunsaturated fatty acids, enzymes, vitamins, nigellone and saponins.

The excipients used to make the tablets are: soy lecithin, glycerol, gelatin, and water.

Both Baraka and Baraka forte contain oil produced from Nigella seeds, also known as ‘black cumin’, but they have different concentrations. Baraka contains 450 mg of Nigella per tablet and Baraka forte contains a higher dose of 500 mg of Nigella per tablet.

Although Baraka is safe when taken in minimal doses, it has been observed that it can cause certain changes in platelets, cells involved in the blood clotting process. If you experience any unpleasant symptoms while using Baraka, stop taking it and seek medical advice.

It is contraindicated in people who are hypersensitive or have allergic reactions to Negrilica seeds or any of the ingredients in the supplement (soy). Do not use in cases of thrombocytopenia (low platelet count) or in people undergoing antithrombotic treatment. Contraindicated during pregnancy.

Baraka is contraindicated in children under 12 years of age.

No, Baraka is not recommended during pregnancy and breastfeeding as there is insufficient data to confirm its safety during these periods.

Baraka does not affect the ability to drive vehicles and/or machinery. However, if you feel tired or drowsy after using this supplement, it is best not to drive or use machinery.

Baraka may alter the action of antithrombotic medication. It is therefore advisable to inform your doctor about any supplements or medications you are taking before using Baraka.